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To the editor: We thank Clement et al. for their inter-
est in our report on the first tick-borne encephalitis 
virus (TBEV) infection in the Netherlands (which was 
acquired in May, but diagnosed in July). They express 
their concerns about the correctness of the diagno-
sis and correctly point out several oddities and diag-
nostic challenges in the case. However, despite these 
uncertainties, we have no doubt that our patient was 
infected with TBEV because of several reasons.
Firstly, we did not rely solely on serological tech-
niques, as the patient had provided us with the tick 
that had bitten him; the species was phenotypically 
not determinable because it had dried. The tick was 
TBEV-positive in qRT-PCR, not for the novel Dutch TBEV 
(a separate manuscript with sequence data of this 
virus is currently under review), but for a TBEV strain 
very closely related to the Neudörfl strain, implying 
the presence of several distinct strains of TBEV in the 
Netherlands. In our opinion, knowing that the patient 
had been bitten by a tick proven to be TBEV-infected, 
drastically increases the chance that compatible symp-
toms and positive anti-TBEV serology was attributable 
to a true TBEV infection.
Secondly, according to the paper by Holzmann and 
the recent European Union case definition for TBE, our 
patient met the criteria for a proven/confirmed TBEV 
infection. These criteria are, among others: symptoms 
of inflammation of the central nervous system and pres-
ence of specific IgM and IgG antibodies in blood and/or 
cerebrospinal fluid (CSF), in the absence of vaccination 
in the previous months [1,2]. In our case, the specificity 
of serum antibodies was confirmed with neutralisation 
tests (NT). Although, based on one study in animals [3], 
the specificity of NT is disputed, we believe the anti-
bodies in our case were specific because NT titres were 
high. As the samples (indeed taken on days 24 and 36) 
were not diluted beyond 1/640 (the goal of the NT was 
to confirm the specificity of our ELISA results), we do 
not know the exact titres and thus their dynamics. In 
the cited animal study, cross-reactivity with louping 
ill virus was observed and all West Nile virus-infected 
horses were negative in TBEV NT [3]. As louping ill virus 
is not known to circulate in the Netherlands, we do not 
believe this has affected our results. Positive anti-
TBEV antibodies may indeed have been due to a yellow 
fever vaccination 11 years earlier, but this is only true 
for IgG. IgM is only detectable for several months after 
vaccination [1]. Furthermore, the substantial decrease 
in anti-TBEV IgM concentration between days 24 and 
36 cannot be explained by this vaccination, but is not 
unusual in a recent TBEV infection [1].
Thirdly, we should indeed have determined a CSF/
serum IgG ratio. We recently determined this ratio and 
found it to be negative. Intrathecally produced anti-
TBEV antibodies are, however, not mandatory for a 
definite diagnosis. Although the presence of intrath-
ecally produced antibodies is indeed supportive of 
the diagnosis, they are not found in all cases. Kaise 
and Holzmann, for example, found that 16% of TBEV-
infected patients did not have intrathecally produced 
anti-TBEV antibodies at hospital admission [4]. More 
recently, Henningsson et al. described a similar case, 
also without anti-TBEV antibodies in CSF [5].
In conclusion, we agree that our case had several 
unusual aspects, such as the predominant mononu-
clear cell reaction in CSF and the lack of intrathecally 
produced anti-TBEV antibodies. We believe, however, 
that our patient had a proven TBEV infection, based 
on the presence of compatible clinical symptoms, the 
presence of TBEV-specific antibodies in two different 
assays and the high levels of TBEV in the tick that had 
bitten the patient
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